Ballentine Partners’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,311
Closed -$298K 902
2024
Q3
$298K Sell
4,311
-3
-0.1% -$194 0.01% 591
2024
Q2
$275K Buy
4,314
+8
+0.2% +$602 0.01% 592
2024
Q1
$405K Buy
4,306
+17
+0.4% +$1.37K 0.01% 447
2023
Q4
$315K Buy
+4,289
New +$275K 0.01% 485

Other funds holding BRKR

Ballentine Partners's BRKR Position: Q4 2024 in Review

Ballentine Partners sold out of Bruker (BRKR) in Q4 2024, closing a stake of 4,311 shares — an estimated $298K sold.

Ballentine Partners first reported a position in BRKR in Q4 2023 and held it in 4 quarters. The position peaked at $405K in Q1 2024. 367 funds tracked by Wall St. Rank hold BRKR as of Q4 2024.

  • Ballentine Partners reported no remaining Bruker position as of Q4 2024 after selling out during the quarter.
  • Ballentine Partners sold 4,311 Bruker shares in Q4 2024, an estimated $298K.
  • Ballentine Partners first reported a position in Bruker in Q4 2023 and held it in 4 quarters.
  • Ballentine Partners's Bruker position peaked at $405K in Q1 2024.
  • 367 funds tracked by Wall St. Rank held Bruker as of Q4 2024.

Based on Ballentine Partners's 13F filing for Q4 2024, filed 16 Jan 2025.